AstraZeneca CEO says AI is reshaping drug development
AstraZeneca CEO Pascal Soriot said AI is helping the company develop medicines faster and make smarter decisions throughout the research process.
TL;DR
- AI improves productivity in drug development by enabling faster and smarter medicine design.
- Practical applications of AI are evident across drug discovery and development stages.
- AI helps in identifying new drug targets and optimizing molecular design.
- AI aids in predicting potential side effects of drug molecules.
- Partnerships with AI companies like Tempus AI help analyze data for better decision-making.
- AI models are used to analyze clinical and laboratory data to predict the success probability of Phase 3 trials.
- Increasing the probability of success in trials leads to enormous productivity improvements, especially given the high costs of drug development.